非酒精性脂肪性肝病发病机制新认识

辛晟梁; 徐可树

doi:10.3969/j.issn.1001-5256.2017.08.037

非酒精性脂肪性肝病发病机制新认识

DOI: 10.3969/j.issn.1001-5256.2017.08.037

华中科技大学同济医学院附属协和医院消化内科

详细信息

中图分类号: R575.5
计量
- 文章访问数: 2083
- HTML全文浏览量: 12
- PDF下载量: 487
- 被引次数: 0
出版历程
- 收稿日期: 2017-02-22
- 出版日期: 2017-08-20

A new understanding of the pathogenesis of nonalcoholic fatty liver disease

Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

摘要

摘要: 近年来我国非酒精性脂肪性肝病(NAFLD)发病率越来越高,达到11%~15%。目前认为"多次打击"学说是NAFLD的主要发病机制,但确切机制尚未明确。从肝脏高表达蛋白质癌胚抗原相关细胞黏附分子1、维生素D受体轴、精神心理因素等较为新颖的角度阐述了其与NAFLD发生发展的关系,以期为今后研究NAFLD发病机制提供新的方向。
- 脂肪肝 /
- 细胞黏附分子 /
- 维生素D /
- 精神障碍 /
- 综述
Abstract: The incidence rate of nonalcoholic fatty liver disease ( NAFLD) has been increasing in China in recent years and has reached11%-15%. At present, the " multiple-hit" hypothesis is considered the main pathogenesis of NAFLD, yet the specific pathogenesis remains unknown. This article elaborates on the roles of carcinoembryonic antigen-related cell adhesion molecule 1 highly expressed in the liver, vitamin D/vitamin D receptor axis, and psychological factors in the development and progression of NAFLD, in order to provide new directions for the research on the pathogenesis of NAFLD in future.
- fatty liver /
- cell adhesion molecules /
- vitamin D /
- mental disorders /
- review

HTML全文

参考文献(20)

[1]NAJJAR SM.Regulation of insulin action by CEACAM1[J].Trends Endocrinol Metab, 2002, 13 (6) :240-245.

[2]MATVEYENKO AV, LIUWANTARA D, GURLO T, et al.Pulsatile portal vein insulin delivery enhances hepatic insulinaction and signaling[J].Diabetes, 2012, 61 (9) :2269-2279.

[3]GHOSH S, KAW M, PATEL PR, et al.Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis[J].Hepat Med, 2010, 2010 (2) :69-78.

[4]COOK JR, LANGLET F, KIDO Y, et al.Pathogenesis of selective insulin resistance in isolated hepatocytes[J].J Biol Chem, 2015, 290 (22) :13972-13980.

[5]NAGAISHI T, PAO L, LIN SH, et al.SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms[J].Immunity, 2006, 25 (5) :769-781.

[6]HEINRICH G, GHADIEH HE, GHANEM SS, et al.Loss of hepatic CEACAM1:a unifying mechanism linking insulin resistance to obesity and non-alcoholic fatty liver disease[J].Front Endocrinol (Lausanne) , 2017, 8:8.

[7]ELIADES M, SPYROU E, AGRAWAL N, et al.Meta-analysis:vitamin D and non-alcoholic fatty liver disease[J].Aliment Pharmacol Ther, 2013, 38 (3) :246-254.

[8]SU D, NIE Y, ZHU A, et al.Vitamin D signaling through induction of paneth cell defensins maintains gut microbiota and improves metabolic disorders and hepatic steatosis in animal models[J].Front Physiol, 2016, 7:498.

[9]ROTH CL, ELFERS CT, FIGLEWICZ DP, et al.Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation[J].Hepatology, 2012, 55 (4) :1103-1111.

[10]KONG M, ZHU L, BAI L, et al.Vitamin D deficiency promotes nonalcoholic steatohepatitis through impaired enterohepatic circulation in animal model[J].Am J Physiol Gastrointest Liver Physiol, 2014, 307 (9) :g883-g893.

[11]ZHU L, KONG M, HAN YP, et al.Spontaneous liver fibrosis induced by long term dietary vitamin D deficiency in adult mice is related to chronic inflammation and enhanced apoptosis[J].Can J Physiol Pharmacol, 2015, 93 (5) :385-394.

[12]HAMZAOUI A, BERRAES A, HAMDI B, et al.Vitamin D reduces the differentiation and expansion of Th17 cells in young asthmatic children[J].Immunobiology, 2014, 219 (11) :873-879.

[13]KESSLER RC, MERIKANGAS KR, WANG PS.Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century[J].Annu Rev Clin Psychol, 2007, 3:137-158.

[14]WEINSTEIR AA, KALLMAN PRICE J, STEPANOVA M, et al.Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C[J].Psychosomatics, 2011, 52 (2) :127-132.

[15]MACAVEI B, BABAN A, DUMITRASCU DL.Psychological factors associated with NAFLD/NASH:a systematic review[J].Eur Rev Med Pharmacol Sci, 2016, 20 (24) :5081-5097.

[16]YOUSSEF NA, ABDELMALEK MF, BINKS M, et al.Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease[J].Liver Int, 2013, 33 (7) :1062-1070.

[17]ELWING JE, LUSTMAN PJ, WANG HL, et al.Depression, anxiety, and nonalcoholic steatohepatitis[J].Psychosom Med, 2006, 68 (4) :563-569.

[18]DAVIES L, KARTHIKEYAN N, LYNCH JT, et al.Cross talk of signaling pathways in the regulation of the glucocorticoid receptor function[J].Mol Endocrinol, 2008, 22 (6) :1331-1344.

[19]MAGDY YM, EL-KHARASHI OA, NABIH ES, et al.Potential involvement of JNK1 repression in the hepatic effect of sitagliptin and metformin in rats subjected to high fat diet and chronic mild distress[J].Biomed Pharmacother, 2017, 85:225-238.

[20]MARDERSTEIN EL, BUCHER B, GUO Z, et al.Protection of rat hepatocytes from apoptosis by inhibition of c-Jun N-terminal kinase[J].Surgery, 2003, 134 (2) :280-284.

施引文献

资源附件(0)

访问统计